LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Open

SectorHealthcare

28.56 0.46

Buy Sell

Overview

Share price change

24h

Current

Min

27.96

Max

28.95

Key metrics
By Trading Economics
Income	-187M -136M
Sales	4.3M 244M
P/E Sector Avg	9.117 66.845
EPS	1.08
Profit margin	-55.871
Employees	293
EBITDA	-22M 52M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+45.61% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	117M 1.7B
Previous open	28.1
Previous close	28.56

News Sentiment

By Acuity

67%

33%

296 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

9 mar 2026, 18:13 UTC

Acquisitions, Mergers, Takeovers

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9 mar 2026, 17:20 UTC

Major News Events

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9 mar 2026, 17:15 UTC

Acquisitions, Mergers, Takeovers

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10 mar 2026, 00:00 UTC

Major News Events

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9 mar 2026, 23:52 UTC

Market Talk

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9 mar 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 mar 2026, 23:46 UTC

Market Talk

Major News Events

Correction to Crude Prices Market Talk on March 9

9 mar 2026, 23:42 UTC

Market Talk

Major News Events

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9 mar 2026, 23:08 UTC

Major News Events

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9 mar 2026, 23:07 UTC

Major News Events

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9 mar 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9 mar 2026, 21:28 UTC

Acquisitions, Mergers, Takeovers

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9 mar 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 mar 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9 mar 2026, 20:47 UTC

Major News Events

The 24 Hours When Oil Markets Went Wild -- WSJ

9 mar 2026, 20:33 UTC

Major News Events

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9 mar 2026, 20:14 UTC

Market Talk

Major News Events

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9 mar 2026, 19:33 UTC

Major News Events

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9 mar 2026, 19:17 UTC

Market Talk

Major News Events

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9 mar 2026, 19:14 UTC

Market Talk

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9 mar 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

9 mar 2026, 18:23 UTC

Market Talk

Major News Events

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9 mar 2026, 17:58 UTC

Acquisitions, Mergers, Takeovers

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9 mar 2026, 17:57 UTC

Acquisitions, Mergers, Takeovers

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9 mar 2026, 17:41 UTC

Major News Events

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9 mar 2026, 17:41 UTC

Market Talk

Major News Events

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9 mar 2026, 17:08 UTC

Market Talk

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9 mar 2026, 17:04 UTC

Market Talk

Major News Events

Global Forex and Fixed Income Roundup: Market Talk

9 mar 2026, 17:04 UTC

Market Talk

Major News Events

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

45.61% upside

12 Months Forecast

Average 41.25 USD 45.61%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

296 / 351 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.